Surgery: light – thermal – and electrical application – Light – thermal – and electrical application – Electrical therapeutic systems
Reexamination Certificate
2001-11-02
2004-07-13
Layno, Carl (Department: 3762)
Surgery: light, thermal, and electrical application
Light, thermal, and electrical application
Electrical therapeutic systems
C607S032000
Reexamination Certificate
active
06763269
ABSTRACT:
TECHNICAL FIELD
The present invention generally relates to implantable medical devices.
BACKGROUND
There are many kinds of implantable medical devices. Some monitor patient conditions while others disperse some form of therapy. One particular type of implantable medical device is an implantable cardiac therapy device, or ICTD. ICTDs are implanted within the body of a patient to monitor, regulate, and/or correct heart activity. ICTDs include implantable cardiac stimulation devices (e.g., implantable cardiac pacemakers, implantable defibrillators) that apply stimulation therapy to the heart as well as implantable cardiac monitors that monitor heart activity.
ICTDs typically include a control unit positioned within a casing that is implanted into the body and a set of leads that are positioned to impart stimulation and/or monitor cardiac activity. With improved processor and memory technologies, the control units have become increasingly more sophisticated, allowing them to monitor many types of conditions and apply tailored stimulation therapies in response to those conditions.
ICTDs are typically capable of being programmed remotely by an external programming device, often called a “programmer”. Today, individual ICTDs are equipped with telemetry circuits that communicate with the programmer. One type of programmer utilizes an electromagnetic wand that is placed near the implanted cardiac device to communicate with the implanted device. The wand contains a coil that forms a transformer coupling with the ICTD telemetry circuitry. The wand transmits low frequency signals by varying the current in a coil.
Early telemetry systems were passive, meaning that the communication was unidirectional from the programmer to the implanted device. Passive telemetry allowed a treating physician to download instructions to the implanted device following implantation. Due to power and size constraints, early commercial versions of the implanted devices were incapable of transmitting information back to the programmer.
As power capabilities improved, active telemetry became feasible, allowing synchronous bi-directional communication between the implanted device and the programmer. Active telemetry utilizes a half-duplex communication mode in which the programmer sends instructions in a predefined frame format and, following termination of this transmission, the implanted device returns data using the frame format. With active telemetry, the treating physician is able to not only program the implanted device, but also retrieve information from the implanted device to evaluate heart activity and device performance. The treating physician may periodically want to review device performance or heart activity data for predefined periods of time to ensure that the device is providing therapy in desired manner. Consequently, current generation implantable cardiac therapy devices incorporate memories, and the processors periodically sample and record various performance parameter measurements in the memories.
Current telemetry systems have a limited communication range between the programmer wand and the ICTD, which is often referred to as “short-range telemetry” or “wand telemetry”. For effective communication, the wand is held within two feet of the ICTD, and typically within several inches. One problem is that the ICTD has insufficient power to transmit longer range signals. Another consideration is the inherent EMI-resistant design of the ICTD. The ICTD circuitry is typically housed in a hermetically shielded can to prevent electromagnetic interference (EMI) from disrupting operation. The can prevents penetration of high frequencies, thereby limiting communication to the low frequency range of less than 200 KHz. In one exemplary system, signals sent from the programmer to the implanted device are transmitted on a carrier of approximately 36 KHz, and data is transmitted to and from the implanted device at approximately 8 KBaud.
Conventionally, data about a patient's cardiac condition is gathered and stored by the programmer during programming sessions of the ICTDs. Analysis of the cardiac condition is performed locally by the programming software. Programmers offer comprehensive diagnostic capabilities, high-speed processing, and easy operation, thereby facilitating efficient programming and timely patient follow-up.
In addition to local analysis, TransTelephonic Monitoring (TTM) systems are employed to gather current cardiac data of patients when the patient is remote from the healthcare provider. TTM systems are placed in patients' homes. They typically include a base unit that gathers information from the ICTD much like the programmer would. The base unit is connected to a telephone line so that data may be transmitted to the medical staff responsible for that patient. An example of an ICTD TTM system is a service from St. Jude Medical® and Raytel® Cardiac Services called “Housecall™.” This service provides current programmed parameters and episode diagnostic information for a plurality of events including stored electrograms (EGMs). Real-time EGMs with annotated status information can also be transmitted.
Using a telephone and a transmitter, the TTM system provides both the medical staff and the patient the convenience of instant analysis of therapy without having the patient leave the comfort of home. Typically, real-time measurements are transmitted in just minutes. Patients may be closely monitored, and the medical staff has more control of their patient's treatment, thus administering better patient management.
While strides have been made for improving patient monitoring, there remains an ongoing need to improve the communication capabilities between implanted devices and external devices, particularly the need to communicate more effectively over greater transmissions ranges.
SUMMARY
A system enables high-frequency communication between an external communication device and one or more implantable medical devices. The system implements a communication protocol in which the external communication device interrogates any implantable medical devices within range to establish one-to-one communication links for purposes of exchanging data and/or programming the medical devices.
In one implementation, the external communication device transmits an interrogation signal on one or more frequencies within a first set of frequencies. The interrogation signal serves as an invitation to communicate with the implantable medical device. The implantable medical device listens for the interrogation signal at a frequency within the first set of frequencies. Upon receipt, the implantable medical device transmits a reply on a second frequency selected from a second set of frequencies. The first and second set of frequencies may overlap or be mutually exclusive. The external communication device monitors the second set of frequencies for the reply. Upon receipt of the reply, the external communication device assigns a communication channel to the implantable medical device for purposes of continuing communication. For that point, the devices can frequency hop among multiple channels more than once during communication of information.
REFERENCES:
patent: 4561443 (1985-12-01), Hogrefe et al.
patent: 4681111 (1987-07-01), Silvian
patent: 5058581 (1991-10-01), Silvian
patent: 5113869 (1992-05-01), Nappholz et al.
patent: 5342408 (1994-08-01), deCoriolis et al.
patent: 5354319 (1994-10-01), Wyborny et al.
patent: 5381798 (1995-01-01), Burrows
patent: 5454838 (1995-10-01), Vallana et al.
patent: 5496351 (1996-03-01), Plicchi et al.
patent: 5496361 (1996-03-01), Moberg et al.
patent: 5511553 (1996-04-01), Segalowitz
patent: 5518001 (1996-05-01), Snell
patent: 5544661 (1996-08-01), Davis et al.
patent: 5562713 (1996-10-01), Silvian
patent: 5617871 (1997-04-01), Burrows
patent: 5674249 (1997-10-01), de Coriolis et al.
patent: 5683432 (1997-11-01), Goedeke et al.
patent: 5697958 (1997-12-01), Paul et al.
patent: 5720770 (1998-02-01), Nappholz et al.
patent: 5748103 (1998-05-01), Flach et al.
patent: 575297
Layno Carl
Pacesetter Inc.
LandOfFree
Frequency agile telemetry system for implantable medical device does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Frequency agile telemetry system for implantable medical device, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Frequency agile telemetry system for implantable medical device will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3259170